In the present study, we elucidated the mechanism of the GPR87-AKT-eNOS-NO pathway for the first time in lung adenocarcinoma; however, further studies are needed to determine whether the GPR87 pathway is the same in other types of cancer. Here, AKT1 is linked to lung adenocarcinoma.